For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

Published Date: 08 May 2024

New research published in the May issue of The Journal of Nuclear Medicine describes how a novel investigational PET imaging agent can quickly and accurately visualize lesions in patients with clear cell renal cell cancer (ccRCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Studies point to redlining as a 'perfect storm' for breast cancer

2.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

3.

Many Americans unaware of links between HPV and cancers, poll reveals

4.

FDA Approves Hemophilia B Second Gene Therapy.

5.

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot